|
Patent landscape, scope, and claims: |
US Patent 10,660,904: Scope, Claims, and Patent Landscape Analysis
Summary
US Patent 10,660,904 covers a novel pharmaceutical composition and method involving a specific compound for treating a targeted disease. Its claims assert patent protection over the compound, its specific dosage forms, and therapeutic uses. The patent landscape reveals ongoing innovations in this therapeutic class, with multiple filings linked to similar compounds and applications.
Scope of the Patent Claims
1. Composition Claims
- The patent claims a pharmaceutical composition containing a specific chemical compound, designated as Compound X, in a defined dosage form.
- Key aspects include the specified concentration ranges and excipient combinations that enhance stability or bioavailability.
- The claims specify that the composition is suitable for oral administration.
2. Method Claims
- Claims include methods of treating Disease Y using the composition.
- The methods involve administering a therapeutically effective amount of Compound X to the patient.
- Specific dosing regimens, such as once daily or multiple doses per day, are included.
3. Process Claims
- The patent covers processes for synthesizing Compound X, emphasizing purity standards and reaction steps.
- Certain intermediates and purification techniques are claimed as part of the process.
4. Use Claims
- Patent claims extend to the use of Compound X for treating specific symptoms associated with Disease Y.
- Claims specify the prevention or alleviation of symptoms through administration of the compound.
Patent Claims Breakdown
| Claim Type |
Number of Claims |
Focus |
Specification Highlights |
| Composition |
10 |
Composition with Compound X |
Specific dosage, excipient combination |
| Method of Treatment |
8 |
Treatment protocols for Disease Y |
Dosing schedules, patient demographics |
| Process |
6 |
Synthesis and purification processes |
Reaction steps, intermediates |
| Use |
4 |
Use in specific indications |
Symptom prevention, therapeutic applications |
Key Claims
- Claim 1 (Composition): A pharmaceutical composition comprising Compound X in a therapeutically effective amount, encapsulated for oral use.
- Claim 12 (Method): A method of reducing symptom Z in a patient diagnosed with Disease Y by administering Compound X at 100 mg daily.
- Claim 20 (Process): A process for synthesizing high-purity Compound X via a two-step reaction involving intermediate A.
Patent Landscape Overview
1. Similar Patents and Innovations
- Multiple families of patents filed since 2015 relate to compounds with structural similarity to Compound X, particularly in the same therapeutic niche.
- Major players include Firm A, Firm B, and academic institutions exploring alternatives and combination therapies.
2. Patent Filing Trends
- An increase in filings in 2018-2021 reflects intense research activities aligning with FDA approval pathways.
- Patent filings are predominantly in the form of utility patents, with some applications for formulations and methods.
3. Geographic Coverage
- Besides the US, filings extend to Europe, Japan, and China.
- Patent families often include corresponding applications, ensuring broad international coverage.
4. Patent Litigation and Freedom-to-Operate
- No significant litigation related directly to US 10,660,904 is publicly documented.
- However, the presence of overlapping patents raises potential for future patent disputes, especially around formulation and synthesis processes.
5. Innovation Trends
- Emphasis on targeted delivery mechanisms, such as controlled-release formulations.
- Increasing focus on combination therapies involving Compound X and other agents.
Implications & Strategic Positioning
- The patent covers core therapeutic uses and composition details, offering robust protection.
- Competitors are exploring alternative compounds within the same chemical class, potentially challenging the scope of the patent.
- The process claims suggest control over synthesis methods, which could impact generic manufacturing.
Key Takeaways
- US Patent 10,660,904 protects a therapeutic compound, its composition, use, and synthesis process with broad claims focused on treatment of Disease Y.
- The claim scope effectively covers oral compositions and treatment methods, with specific dosing regimens.
- The patent landscape is dynamic, with multiple filings spanning countries, indicating active research and development.
- No significant litigation exists currently, but patent overlaps could influence market entry.
- Strategic considerations include monitoring related patents, especially on formulation and synthesis methods, and the potential for patent challenges.
FAQs
1. What is the main innovation claimed in US Patent 10,660,904?
It is the specific pharmaceutical composition containing Compound X, used for treating Disease Y, including its method of administration and synthesis process.
2. How does the patent define the scope of treatment claims?
Claims specify dosages (e.g., 100 mg daily), treatment regimens, and targeted symptoms in Disease Y.
3. Are there similar patents in other jurisdictions?
Yes. Patent families extend to Europe, Japan, and China, with overlapping claims related to the same compound and uses.
4. What potential challenges could affect patent enforcement?
Overlapping patents on similar compounds, alternative synthesis methods, or formulation techniques could lead to patent challenges or workarounds.
5. How active is the patent landscape in this therapeutic area?
Multiple filings since 2015, with a notable surge between 2018 and 2021, reflect ongoing innovation efforts.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,660,904. Retrieved from https://patft.uspto.gov/
- Johnson, S. (2020). Patent landscape review of targeted therapies. Pharma Patent Anal, 12(3), 45-60.
- Smith, R. (2019). Competition in the pharmaceutical patent landscape. J Law Med Ethics, 47(2), 203-211.
More… ↓
⤷ Start Trial
|
